Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma Variations

It has become clear that rituximab treatment is useful for both B-cell malignancies and autoimmune rheumatic diseases. However this treatment is associated with an increased risk of an allergic reaction. We have reviewed the frequency with which these reactions occur in these different conditions. T...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Sergio Gilaberte Reyzabal, David Isenberg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Subjects:	systemic lupus erythematosus rheumatoid arthritis B-cell depletion B-cell malignances allergic reaction
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.882891/full